Annual ROA
-229.72%
-99.53%-76.45%
December 31, 2023
Summary
- As of February 8, 2025, CYTH annual return on assets is -229.72%, with the most recent change of -99.53% (-76.45%) on December 31, 2023.
- During the last 3 years, CYTH annual ROA has fallen by -132.00% (-135.08%).
- CYTH annual ROA is now -514.58% below its all-time high of 55.41%, reached on December 31, 2007.
Performance
CYTH ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROA
-344.63%
-51.47%-17.56%
September 30, 2024
Summary
- As of February 8, 2025, CYTH quarterly return on assets is -344.63%, with the most recent change of -51.47% (-17.56%) on September 30, 2024.
- Over the past year, CYTH quarterly ROA has dropped by -29.26% (-9.28%).
- CYTH quarterly ROA is now -626.15% below its all-time high of 65.50%, reached on December 31, 2007.
Performance
CYTH Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROA Formula
ROA = Net Income
Total Assets ✕ 100%
Total Assets ✕ 100%
CYTH ROA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -76.5% | -9.3% |
| 3 y3 years | -135.1% | -9.3% |
| 5 y5 years | -35.1% | -9.3% |
CYTH ROA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -171.0% | at low | -317.8% | +3.9% |
| 5 y | 5-year | -171.0% | at low | -317.8% | +3.9% |
| alltime | all time | -514.6% | at low | -626.1% | +3.9% |
Cyclo Therapeutics ROA History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -344.63%(+17.6%) |
| Jun 2024 | - | -293.16%(+5.1%) |
| Mar 2024 | - | -279.05%(-11.5%) |
| Dec 2023 | -229.72%(+76.4%) | -315.37%(-12.1%) |
| Sep 2023 | - | -358.65%(+26.5%) |
| Jun 2023 | - | -283.48%(+42.9%) |
| Mar 2023 | - | -198.43%(+54.1%) |
| Dec 2022 | -130.19%(+53.6%) | -128.78%(+29.9%) |
| Sep 2022 | - | -99.17%(+11.9%) |
| Jun 2022 | - | -88.65%(+7.5%) |
| Mar 2022 | - | -82.49%(-10.9%) |
| Dec 2021 | -84.77%(-13.3%) | -92.54%(-19.3%) |
| Sep 2021 | - | -114.67%(+3.4%) |
| Jun 2021 | - | -110.91%(-12.1%) |
| Mar 2021 | - | -126.12%(-23.9%) |
| Dec 2020 | -97.72%(-54.4%) | -165.70%(-30.5%) |
| Sep 2020 | - | -238.45%(+16.1%) |
| Jun 2020 | - | -205.44%(+8.2%) |
| Mar 2020 | - | -189.87%(+12.9%) |
| Dec 2019 | -214.26%(+26.1%) | -168.22%(+8.2%) |
| Sep 2019 | - | -155.43%(-5.0%) |
| Jun 2019 | - | -163.63%(-36.4%) |
| Mar 2019 | - | -257.35%(+27.9%) |
| Dec 2018 | -169.98%(-12.3%) | -201.26%(-7.5%) |
| Sep 2018 | - | -217.53%(+7.1%) |
| Jun 2018 | - | -203.02%(+16.9%) |
| Mar 2018 | - | -173.68%(-0.3%) |
| Dec 2017 | -193.73%(+51.6%) | -174.23%(+29.0%) |
| Sep 2017 | - | -135.07%(-5.3%) |
| Jun 2017 | - | -142.57%(+6.2%) |
| Mar 2017 | - | -134.23%(+19.8%) |
| Dec 2016 | -127.81%(+151.1%) | -112.07%(+15.0%) |
| Sep 2016 | - | -97.45%(+31.1%) |
| Jun 2016 | - | -74.36%(+24.5%) |
| Mar 2016 | - | -59.75%(+18.3%) |
| Dec 2015 | -50.90%(+246.7%) | -50.50%(+45.6%) |
| Sep 2015 | - | -34.69%(+31.3%) |
| Jun 2015 | - | -26.42%(+13.8%) |
| Mar 2015 | - | -23.21%(+65.3%) |
| Dec 2014 | -14.68%(-293.7%) | -14.04%(+45.6%) |
| Sep 2014 | - | -9.64%(+32.2%) |
| Jun 2014 | - | -7.29%(-218.3%) |
| Mar 2014 | - | 6.16%(-15.8%) |
| Dec 2013 | 7.58%(+176.6%) | 7.32%(-51.6%) |
| Sep 2013 | - | 15.13%(-11.2%) |
| Jun 2013 | - | 17.04%(+212.7%) |
| Mar 2013 | - | 5.45%(+99.6%) |
| Dec 2012 | 2.74% | 2.73%(-157.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2012 | - | -4.76%(-5.7%) |
| Jun 2012 | - | -5.05%(+209.8%) |
| Mar 2012 | - | -1.63%(-60.3%) |
| Dec 2011 | -4.14%(+77.7%) | -4.11%(-325.8%) |
| Sep 2011 | - | 1.82%(-33.3%) |
| Jun 2011 | - | 2.73%(+8.8%) |
| Mar 2011 | - | 2.51%(-203.7%) |
| Dec 2010 | -2.33%(-84.8%) | -2.42%(-89.5%) |
| Sep 2010 | - | -22.96%(+17.0%) |
| Jun 2010 | - | -19.62%(-14.1%) |
| Mar 2010 | - | -22.84%(+13.5%) |
| Dec 2009 | -15.29%(-47.6%) | -20.12%(-28.6%) |
| Sep 2009 | - | -28.16%(-6.0%) |
| Jun 2009 | - | -29.96%(+3.6%) |
| Mar 2009 | - | -28.92%(+1.4%) |
| Dec 2008 | -29.20%(-152.7%) | -28.51%(-195.0%) |
| Sep 2008 | - | 30.02%(-22.1%) |
| Jun 2008 | - | 38.55%(-24.7%) |
| Mar 2008 | - | 51.22%(-21.8%) |
| Dec 2007 | 55.41%(-514.7%) | 65.50%(+243.5%) |
| Sep 2007 | - | 19.07%(+483.2%) |
| Jun 2007 | - | 3.27%(-132.7%) |
| Mar 2007 | - | -10.00%(-23.3%) |
| Dec 2006 | -13.36%(-31.3%) | -13.03%(-73.9%) |
| Sep 2006 | - | -49.98%(+3.8%) |
| Jun 2006 | - | -48.16%(+17.1%) |
| Mar 2006 | - | -41.12%(+135.8%) |
| Dec 2005 | -19.44%(-67.6%) | -17.44%(+83.2%) |
| Sep 2005 | - | -9.52%(+674.0%) |
| Jun 2005 | - | -1.23%(-96.4%) |
| Mar 2005 | - | -33.79%(-42.9%) |
| Dec 2004 | -59.96%(-249.2%) | -59.22%(+524.0%) |
| Sep 2004 | - | -9.49%(+10.7%) |
| Jun 2004 | - | -8.57%(-122.0%) |
| Mar 2004 | - | 39.02%(-18.1%) |
| Dec 2003 | 40.18%(+16.2%) | 47.67%(+3057.0%) |
| Sep 2003 | - | 1.51%(-88.8%) |
| Jun 2003 | - | 13.51%(-31.7%) |
| Mar 2003 | - | 19.77%(-39.5%) |
| Dec 2002 | 34.57%(-254.8%) | 32.66%(+2.4%) |
| Sep 2002 | - | 31.88%(+707.1%) |
| Jun 2002 | - | 3.95%(-162.1%) |
| Mar 2002 | - | -6.36%(-70.8%) |
| Dec 2001 | -22.33%(-60.7%) | -21.79%(-32.3%) |
| Sep 2001 | - | -32.19%(-3.2%) |
| Jun 2001 | - | -33.24%(+3.6%) |
| Mar 2001 | - | -32.09%(+23.1%) |
| Dec 2000 | -56.80% | -26.06%(+212.1%) |
| Sep 2000 | - | -8.35% |
FAQ
- What is Cyclo Therapeutics annual return on assets?
- What is the all time high annual ROA for Cyclo Therapeutics?
- What is Cyclo Therapeutics annual ROA year-on-year change?
- What is Cyclo Therapeutics quarterly return on assets?
- What is the all time high quarterly ROA for Cyclo Therapeutics?
- What is Cyclo Therapeutics quarterly ROA year-on-year change?
What is Cyclo Therapeutics annual return on assets?
The current annual ROA of CYTH is -229.72%
What is the all time high annual ROA for Cyclo Therapeutics?
Cyclo Therapeutics all-time high annual return on assets is 55.41%
What is Cyclo Therapeutics annual ROA year-on-year change?
Over the past year, CYTH annual return on assets has changed by -99.53% (-76.45%)
What is Cyclo Therapeutics quarterly return on assets?
The current quarterly ROA of CYTH is -344.63%
What is the all time high quarterly ROA for Cyclo Therapeutics?
Cyclo Therapeutics all-time high quarterly return on assets is 65.50%
What is Cyclo Therapeutics quarterly ROA year-on-year change?
Over the past year, CYTH quarterly return on assets has changed by -29.26% (-9.28%)